Skip to content

Clinical trials

Phase 2 Cardiomyopathy, Dilated trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Phase: Phase 2 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20093
20101
20113
20143
20151
20161
20181
20192
20204
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting2
Terminated2
Active, not recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Medical Centre Ljubljana3
Barts & The London NHS Trust2
National Taiwan University Hospital2
Pfizer2
Vericel Corporation2
Ain Shams University1
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud1
Bambino Gesù Hospital and Research Institute1
Berlin Cures GmbH1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated25
Heart Failure10
Cardiomyopathies3
Laminopathies2
Campomelic Dysplasia1
Coronary Disease1
Distal Myopathies1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.